These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 16152706)

  • 1. Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children.
    Viganò A; Giacomet V
    Antivir Ther; 2005; 10 Suppl 2():M53-64. PubMed ID: 16152706
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy.
    McComsey G
    AIDS Rev; 2002; 4(3):140-7. PubMed ID: 12416448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine].
    Charton-Bain MC; Flamant M; Aubertin JM; Belair MF; Gilquin J; Kazatchkine M; Bruneval P
    Gastroenterol Clin Biol; 1997; 21(12):979-81. PubMed ID: 9587562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term complications of nucleoside reverse transcriptase inhibitor therapy.
    Dieterich DT
    AIDS Read; 2003 Apr; 13(4):176-84, 187. PubMed ID: 12741368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for mitochondrial toxicity: lactic acidosis as proof of concept.
    Brinkman K
    J HIV Ther; 2001 Mar; 6(1):13-6. PubMed ID: 11501196
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of zidovudine in development of lipoatrophy.
    Moyle GJ
    AIDS Read; 2005 Nov; 15(11):591-4, 599-600, 603. PubMed ID: 16329181
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment.
    Vrouenraets SM; Treskes M; Regez RM; Troost N; Smulders YM; Weigel HM; Frissen PH; Brinkman K
    Antivir Ther; 2002 Dec; 7(4):239-44. PubMed ID: 12553477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactic acidosis secondary to nucleoside analogue antiretroviral therapy.
    Khouri S; Cushing H
    AIDS Read; 2000 Oct; 10(10):602-6. PubMed ID: 11068807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
    Calza L; Manfredi R; Chiodo F
    Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical mitochondrial dysfunction in uninfected children born to HIV-infected mothers following perinatal exposure to nucleoside analogues.
    Benhammou V; Tardieu M; Warszawski J; Rustin P; Blanche S
    Environ Mol Mutagen; 2007; 48(3-4):173-8. PubMed ID: 17358031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial response: hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors.
    Brinkman K
    Clin Infect Dis; 2000 Jul; 31(1):167-9. PubMed ID: 10913416
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible ways nucleoside analogues can affect mitochondrial DNA content and gene expression during HIV therapy.
    Côté HC
    Antivir Ther; 2005; 10 Suppl 2():M3-11. PubMed ID: 16152702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Of power plants and energy shortages.
    TreatmentUpdate; 2001 May; 13(1):3-4. PubMed ID: 11570256
    [No Abstract]   [Full Text] [Related]  

  • 14. Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors.
    Claessens YE; Chiche JD; Mira JP; Cariou A
    Crit Care; 2003 Jun; 7(3):226-32. PubMed ID: 12793872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic hyperlactatemia in a patient on nucleoside reverse transcriptase inhibitors.
    Ball SC
    AIDS Read; 2001 Dec; 11(12):593-5. PubMed ID: 11806170
    [No Abstract]   [Full Text] [Related]  

  • 16. Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.
    Shah SS; Rodriguez T; McGowan JP
    Clin Infect Dis; 2003 May; 36(10):e131-3. PubMed ID: 12746793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly active antiretroviral therapy (HAART)-associated lactic acidosis: in vitro effects of combination of nucleoside analogues and protease inhibitors on mitochondrial function and lactic acid production.
    Nerurkar PV; Pearson L; Frank JE; Yanagihara R; Nerurkar VR
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1205-11. PubMed ID: 14983988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity.
    Moyle G
    Clin Ther; 2000 Aug; 22(8):911-36; discussion 898. PubMed ID: 10972629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
    Koh MT
    Int J Infect Dis; 2007 Jan; 11(1):85-6. PubMed ID: 16581278
    [No Abstract]   [Full Text] [Related]  

  • 20. A cautionary tale: fatal lactic acidosis complicating nucleoside analogue and metformin therapy.
    Worth L; Elliott J; Anderson J; Sasadeusz J; Street A; Lewin S
    Clin Infect Dis; 2003 Jul; 37(2):315-6. PubMed ID: 12856228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.